Ovia Health
→
LabCorp
Acquisition · Cash · LH · announced Aug 12, 2021
Announced
Aug 12, 2021
Closed
Aug 12, 2021
Economics
Undisclosed
Cash
Acquisition terms not publicly disclosed by LabCorp; Ovia cited ~$20M annual revenue at close
Target
Ovia Health
Maternal Health · Care delivery
HQ Boston, MA · Founded 2012
Digital health platform for family planning, pregnancy, and parenting — used by millions of women for fertility tracking, prenatal care, and employer health benefits
- Business Wire — LabCorp press release (Aug 12, 2021)
- LabCorp investor relations — Ovia Health announcement
- Boston Globe — deal coverage (Aug 16, 2021)
Acquirer
LabCorp (LH)
Diagnostics
HQ Burlington, NC
Why this buyer
Curated copy from the verified dataset — not an 8-K LLM summary
Digital platform for family planning, pregnancy, and parenting — extends LabCorp's women's health leadership by combining diagnostic testing with personalized digital health experiences for millions of users
Evidence ladder
Secondary (press / IR)
Business Wire — LabCorp press release (Aug 12, 2021)
Tertiary (trade / analyst)
LabCorp investor relations
Primary (regulatory / filing)
SEC EDGAR 8-K https://www.sec.gov/Archives/edgar/data/920148/000092014821000053/form81221ex991oviaacquisit.htm
Open source
Limitations
- Deal value not disclosed in verified record; multiples and comparables exclude this transaction.
Valuation peers · Maternal Health
Same sector, same deal type, announced within ±3 years, disclosed value within 0.25×–4× of this transaction. Ranked by evidence class, then same acquirer, until you sort.
Insufficient disclosed data
No verified Maternal Health deals meet the peer rule: same deal type, announced within ±3 years, and a disclosed value inside 0.25×–4× of this transaction.
Other verified deals by LabCorp
Acquirer program history not already listed as a valuation peer or adjacency row.
| Sector | ||||
|---|---|---|---|---|
| BioReference Health (clinical, women's health, urology and 4Kscore assets) | LabCorp | Oct 15, 2026 | Diagnostics | |
| BioReference Health (clinical diagnostics and reproductive & women's health, outside NY/NJ) | LabCorp | Mar 28, 2024 | Diagnostics | |
| Sequenom | LabCorp | Jul 27, 2016 | Diagnostics |
Patient empowerment context
Patient empowerment baseline (HLTH 2022)
No curated mapping — Ovia Health (Maternal Health). HLTH/Outcomes4Me 2022 baseline is Breast cancer care continuum (HLTH 2022). No curated mapping for this target in the verified crosswalk.
Research workspace (includes heuristic crosswalk) →Related verified workspaces
Lacuna is a curated public-source sample, not a census of women's-health M&A. Coverage varies by sector, geography, disclosure availability, and women's-health scope. Undisclosed transaction values are excluded from disclosed-value totals.
Curated verified dataset v11 · updated 2026-10-19 · 3 citations on this deal · Data compiled from public sources for educational visualization. Verify independently before any commercial use.